Tampa, Fla.-based Moffitt Cancer Center has partnered with biopharmaceutical company AbbVie to accelerate cancer therapy development.
The five-year partnership will combine Moffitt’s clinical expertise with AbbVie’s oncology research capabilities through “early-stage programs, translational and clinical research, and real-world evidence data generation,” according to an Oct. 14 news release from cancer center.
“Combining AbbVie’s drug development expertise with our clinical capabilities will accelerate discovery and testing of new treatments,” Karen Lu, MD, physician-in-chief at Moffitt, said in the release. “Our goal is to improve outcomes through focused research and efficient clinical trials that translate science into care without delay.”
Leave a Reply